NFKB1 and classic Hodgkin lymphoma: Translocations in the histocompatibility complex type II transactivator CIITA causing downregulation of MHC II are present in 15% of CHL cases and 38% of PMBL [25,42] and recurrent mutations occur in genes involved in the nuclear factor κB (NF-κB) pathway resulting in its constitutive activation.